Daniel O'Connell - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Daniel O'Connell

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

The New England Journal of Medicine|July 2, 2021

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisJulian D Gillmore, Ed Gane, Jorg Taubel, et al.

Science Translational Medicine|February 9, 2022

CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell functionEliana Ruggiero, Erica Carnevale, Aaron Prodeus, et al.

Elife|June 23, 2021

Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorptionCheng-Chia Tang, Christian D Castro Andrade, Maureen J O'Meara, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

The New England Journal of Medicine|July 2, 2021

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisJulian D Gillmore, Ed Gane, Jorg Taubel, et al.

Science Translational Medicine|February 9, 2022

CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell functionEliana Ruggiero, Erica Carnevale, Aaron Prodeus, et al.

Elife|June 23, 2021

Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorptionCheng-Chia Tang, Christian D Castro Andrade, Maureen J O'Meara, et al.

Pageof 6